Flodil LP (felodipine extended-release) is a medicine approved to help manage symptoms and support the treatment of established cardiovascular conditions. The key indications for its use are the management of arterial hypertension, which is high blood pressure, and the preventive management of stable angina pectoris, which is recurring chest pain. The medication works to assist with blood pressure control and may help reduce associated physical discomfort.

This therapeutic effect is generally associated with supporting symptom reduction and helping with the long-term management of these underlying conditions. Physicians may prescribe Flodil LP as a standalone treatment or in combination with other necessary therapies.

Quick Fact: Relief for Hypertension and Angina

Who can and cannot use Flodil LP?

This information is based strictly on governmental regulatory documents detailing the official population eligibility and non-eligibility for Felodipine prolonged-release tablets.

Eligibility Restrictions and Prohibitions

Category	Regulatory Status
Absolute Contraindications	Use is prohibited in patients with known Hypersensitivity to Felodipine or any excipients. It is also contraindicated in cases of Acute Myocardial Infarction, Unstable Angina Pectoris, and Decompensated Heart Failure.
Pregnancy/Lactation	Use is contraindicated during Pregnancy. It is not recommended for women who are Breastfeeding.
Pediatric Patients	Safety and efficacy have not been established in children and adolescents (under 18 years).
Older Adults	Use is permitted, but treatment should be initiated with the lowest available dose.
Hepatic Function	Use requires caution in patients with Impaired Hepatic Function, and an initial low dose may be recommended due to slower metabolism.
Renal Function	Use is generally permitted, and no dose adjustment is typically required for patients with impaired renal function.

Eligibility Scope

The medicine is approved for use in Adults (18 years and older) under standard labeled conditions for high blood pressure and stable angina pectoris.

Interactions with other medicines and products

Flodil LP is metabolized by the enzyme system Cytochrome P450 3A4 (CYP3A4) in the liver, making its plasma concentration susceptible to changes when combined with other agents that affect this enzyme. These documented interactions structure the product's official interaction profile, leading to specific use constraints.

Combinations to Avoid

• Strong CYP3A4 Inducers: Co-administration with strong enzyme inducers is advised to be avoided because they significantly decrease the concentration of Flodil LP in the bloodstream. Examples include anticonvulsant medicines such as phenytoin, carbamazepine, and phenobarbital, as well as rifampicin and the herbal supplement St. John’s Wort (Hypericum perforatum).
• Grapefruit Juice: The consumption of grapefruit or grapefruit juice should be avoided as it inhibits CYP3A4, which can lead to a several-fold increase in the drug's plasma concentration.

Combinations Requiring Caution or Monitoring

• Strong CYP3A4 Inhibitors: Certain strong inhibitors, such as the antifungal medicines itraconazole and ketoconazole, and the antibiotic erythromycin, can substantially increase the concentration of Flodil LP. This combination requires caution, and a dose adjustment may be necessary.
• Other Antihypertensive Agents: Co-administration with other medicines that lower blood pressure, such as certain alpha-blockers or vasodilators, may result in an additive hypotensive effect.
• Tacrolimus: Flodil LP may increase the blood concentration of tacrolimus, an immunosuppressant. Official documentation requires that the concentration of tacrolimus in the blood be monitored, and its dose may need adjustment if used concomitantly.

The mechanism of Flodil LP (Felodipine) is defined by its highly specific action on calcium channels within the peripheral vasculature, leading to a resulting modulation of blood vessel tone.

Flodil LP acts as an antagonist at the L-type Voltage-Gated Calcium Channels ( Ca v1.2), the primary molecular target found in the walls of the smallest peripheral arteries (arterioles). By binding to these channels, the drug blocks the influx of calcium ions ( Ca^2+), which are required for smooth muscle contraction. This targeted inhibition is the critical first step in interrupting the excitation-contraction coupling pathway.

The resulting lack of intracellular calcium prevents the activation of key enzymes like Myosin Light-Chain Kinase (MLCK), causing the smooth muscle to relax. This cellular relaxation leads to arteriolar vasodilation (widening), which results in a reduction of the overall Total Peripheral Resistance (TPR) in the circulatory system. This mechanism, focused on altering the resistance against which the blood flows, results in the mechanism's primary physiological consequence.

The mechanism is characterized by vascular selectivity for the arterioles and does not exert a direct effect on the heart's conduction system. However, this selectivity results in an imbalance between precapillary and postcapillary pressure dynamics. Furthermore, the baroreceptor reflex may trigger a compensatory increase in heart rate in response to the rapid drop in TPR.

How to Use Flodil LP: Administration Guidelines

Flodil LP is a prolonged-release tablet containing the active ingredient felodipine. Its use is guided by instructions to ensure consistent and controlled release of the medicine, avoiding issues with the extended-release mechanism.

---

Administration Scope

Feature	Guideline
Route of Administration	The medicine must be taken orally (by mouth).
Dosing Schedule (Adults)	Starting Dose: Typically 5 mg once daily. Maintenance Range: Usually 5 mg to 10 mg once daily. Dosage adjustments are made at intervals of at least two weeks.
Timing in relation to meals	May be administered without food or following a light meal. Consumption with grapefruit juice is strictly prohibited.
Age-Group Rules	Older Adults (Geriatric): Treatment should begin with a lower dose of 2.5 mg once daily. Pediatric: Safety and efficacy are not established.
Missed-Dose Rules	If a dose is missed, the patient should skip the missed dose and take the next dose at the regular time. A double dose must not be taken.

---

Procedural Instructions

Flodil LP must be taken once daily, preferably at the same time each morning.

Procedural Sequence:

• The tablet must be swallowed whole; it must not be crushed, cut, or chewed, as this would compromise the prolonged-release mechanism.
• Administer the tablet without food or with a light meal, and ensure no grapefruit juice is consumed near the time of dosing.

These instructions define the standardized approach to using Flodil LP, focusing on preserving the controlled-release function and managing systemic absorption for consistency in administration.

Research Evidence for Arterial Hypertension (High Blood Pressure)

Research for Flodil LP in arterial hypertension has utilized study designs, including large-scale Randomized Controlled Trials (RCTs). These trials evaluated changes in Systolic and Diastolic Blood Pressure and examined long-term Major Cardiovascular Events like stroke and heart attack over several years. Findings describe patterns observed in these studies where felodipine was associated with differences in measured blood pressure and certain long-term event rates. However, long-term effects are not fully established for every scenario, as some large studies explored felodipine when used in combination with other medicines, meaning data is limited for monotherapy.

---

Research Evidence for Stable Angina Pectoris (Recurring Chest Pain)

For stable angina pectoris, research was evaluated in studies that focused on symptom-related outcomes. These were typically short-term, randomized comparative trials that monitored the weekly frequency of angina attacks and functional measures, such as Time to Onset of Angina during exercise testing. The studies report how symptoms evolved in the observed populations during the study periods. The evidence for angina is derived from short-term trials, and consequently, the follow-up durations were limited, meaning there is limited information for long-term outcomes specific to preventing major cardiovascular events.

---

Long-Term Research and Durability of Study Findings

Long-term studies, primarily focused on hypertension, monitored patients for periods extending up to several years. Research examined whether patterns of blood pressure measurements were maintained over time and whether associations with major outcomes were present. These long-term findings contribute to understanding symptom patterns but do not provide individual predictions.

---

Evidence in Specific Patient Populations

Research has specifically studies explored the use of felodipine in older adults, including those with isolated systolic hypertension. These studies report patterns related to blood pressure measurements in these groups. However, data for certain groups remain insufficient when considering highly specific comorbidities.

---

What Research is Still Uncertain or Missing

A key limitation is that many large outcome studies involved combination therapy, resulting in limited information for long-term outcomes when the medicine is used alone. Furthermore, data for certain groups remain insufficient, particularly for pediatric populations, where the medicine was not studied for use in the same manner as in adults.

Common questions about Flodil LP (FAQ)

---

Q: Does Flodil LP work right away, or does it take time to notice a difference?

A: Official product information describes that a reduction in blood pressure typically begins within 2 to 5 hours of taking the medicine. For chronic conditions, substantial blood pressure control is noted to last for approximately 24 hours, as described for chronic use.

---

Q: Do studies show that Flodil LP is effective for its main use?

A: Regulatory indications state that Flodil LP is used for the control of hypertension (high blood pressure) and stable angina pectoris (recurring chest pain). Clinical studies examined dose-related decreases in blood pressure in populations with these conditions.

---

Q: Why is Flodil LP called 'LP'?

A: The abbreviation LP stands for Long Period or Prolonged-release. This term is used to classify the tablet as an extended-release formulation, meaning the active medicine is designed to be released gradually into the body over a longer time.

---

Q: Is Flodil LP generally suitable for older patients?

A: Official documents define eligibility for use in older patients. Regulatory guidelines advise starting treatment with the lowest available dose. This is due to observations that older patients may have higher concentrations of the medicine in their blood.

---

Q: Does alcohol change the way Flodil LP works in the body?

A: Official documents describe the potential for interactions with alcohol. Alcohol and this medicine may have additive effects in lowering blood pressure, which could potentially result in symptoms like dizziness, lightheadedness, or fainting.

---

Q: How long does the effect of one dose of Flodil LP typically last?

A: The formulation is specifically designed for once-daily dosing. Official information states that during long-term use, the blood pressure control provided by the medicine is described as lasting for approximately 24 hours.

---

Q: Is it common for Flodil LP to cause stomach upset?

A: Gastrointestinal side effects like nausea and abdominal pain are listed in safety documents as uncommon, meaning they occur in less than 1% of patients. Constipation is listed as common. Official safety documents indicate that these types of reactions are often transient.

---

Q: Can Flodil LP cause changes in sleep patterns?

A: The official safety profile lists insomnia (difficulty sleeping) as a reported adverse reaction. This is often listed with a frequency that is not known, meaning it has been reported but how often it occurs in trials is not fully established.

---

Q: Are there known weight changes associated with taking Flodil LP?

A: Some regulatory documents note that unusual weight gain or loss and rapid weight gain have been reported. These changes are often associated with fluid retention, which is also a documented side effect (oedema).

---

Q: Can I buy Flodil LP without a prescription?

A: Flodil LP, which contains the active ingredient felodipine, is classified as an oral prescription-only medication in all major regulatory jurisdictions. Its status as a prescription-only medication means a prescription is required for dispensing.

---

Q: Do patients generally tolerate Flodil LP well?

A: Official safety documents describe that the medicine is generally tolerated. Common side effects, such as headache and flushing, are documented as transient and often lessen over time.

---

Q: Is Flodil LP used to treat sudden or acute problems?

A: Flodil LP is indicated for hypertension and stable angina pectoris, both of which are chronic, long-term conditions. Its use is not indicated for the treatment of sudden or acute problems like hypertensive emergencies or acute myocardial infarction.

---

Q: Are there common mental or mood-related changes linked to Flodil LP?

A: Regulatory sources report that adverse reactions may include confusion, and in some cases, symptoms like feeling sad or empty or discouragement. The frequency of these changes is typically listed as incidence not known.

---

Q: What kind of monitoring might a doctor recommend while taking Flodil LP?

A: Official documentation describes the type of monitoring advised, noting that blood pressure should be monitored closely during initial use and after any dose adjustment. Good dental hygiene is also mentioned in regulatory information as advised to minimize the risk of gum swelling.

---

Q: Does Flodil LP cause problems with driving or operating machinery?

A: Official documents state that the medicine has a minor or moderate influence on the ability to drive or use machines. Caution is recommended if a patient experiences side effects like headache, dizziness, nausea, or fatigue, especially when starting treatment.

---

Q: Is it possible to take too much Flodil LP?

A: Yes, taking an excessive amount of Flodil LP (overdosage) is possible. Official safety information indicates that this may cause excessive widening of the blood vessels, resulting in marked hypotension (severely low blood pressure) and sometimes a slowed heart rate (bradycardia).

---

Q: Does Flodil LP affect blood sugar levels?

A: Research has studied the use of the active ingredient in people who have diabetes. While some studies noted minor changes in a glucose measure, these were generally not described as clinically significant in the context of the study.

The official instructions for Flodil LP (felodipine prolonged-release tablets) define mandatory conditions to maintain its stability and ensure safety.

Storage Requirements

The medication must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). Storage areas must be kept away from excess heat, moisture, and direct light, and the product must be kept from freezing. It is required to keep the tablets in the container they came in, with the container kept tightly closed.

Handling and Disposal

To preserve the prolonged-release properties, the tablets must not be crushed or chewed. Flodil LP must be kept out of the sight and reach of children and pets. For disposal, do not keep outdated or unused medicine; patients are directed to ask a healthcare professional how to dispose of the product according to local requirements.